Comparison of One and Three Intraventricular Injections of Cardiac Progenitor Cells in a Murine Model of Chronic Ischemic Cardiomyopathy

[1]  P. Lorkiewicz,et al.  Cardiac mesenchymal cells from diabetic mice are ineffective for cell therapy-mediated myocardial repair , 2018, Basic Research in Cardiology.

[2]  R. Bolli,et al.  New Paradigms in Cell Therapy: Repeated Dosing, Intravenous Delivery, Immunomodulatory Actions, and New Cell Types. , 2018, Circulation research.

[3]  R. Bolli,et al.  Repeated Administrations of Cardiac Progenitor Cells Are Superior to a Single Administration of an Equivalent Cumulative Dose , 2018, Journal of the American Heart Association.

[4]  R. Bolli,et al.  Myocardial Reparative Properties of Cardiac Mesenchymal Cells Isolated on the Basis of Adherence. , 2017, Journal of the American College of Cardiology.

[5]  R. Bolli.  Repeated Cell Therapy: A Paradigm Shift Whose Time Has Come , 2017, Circulation research.

[6]  R. Bolli,et al.  Repeated doses of cardiac mesenchymal cells are therapeutically superior to a single dose in mice with old myocardial infarction , 2017, Basic Research in Cardiology.

[7]  R. Bolli,et al.  Repeated Administrations of Cardiac Progenitor Cells Are Markedly More Effective Than a Single Administration: A New Paradigm in Cell Therapy. , 2016, Circulation research.

[8]  R. Bolli,et al.  Long-Term Outcome of Administration of c-kit(POS) Cardiac Progenitor Cells After Acute Myocardial Infarction: Transplanted Cells Do not Become Cardiomyocytes, but Structural and Functional Improvement and Proliferation of Endogenous Cells Persist for at Least One Year. , 2016, Circulation research.

[9]  R. Bolli,et al.  c-kit+ Cardiac Stem Cells Alleviate Post-Myocardial Infarction Left Ventricular Dysfunction Despite Poor Engraftment and Negligible Retention in the Recipient Heart , 2014, PloS one.

[10]  R. Bolli,et al.  A highly sensitive and accurate method to quantify absolute numbers of c-kit+ cardiac stem cells following transplantation in mice , 2013, Basic Research in Cardiology.

[11]  R. Bolli,et al.  Intracoronary administration of cardiac stem cells in mice: a new, improved technique for cell therapy in murine models , 2011, Basic Research in Cardiology.

[12]  R. Bolli,et al.  Postinfarct Cytokine Therapy Regenerates Cardiac Tissue and Improves Left Ventricular Function , 2006, Circulation research.

[13]  J. Gardin,et al.  American Society of Echocardiography recommendations for use of echocardiography in clinical trials. , 2004, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[14]  B. A. French,et al.  Gene Therapy With Extracellular Superoxide Dismutase Protects Conscious Rabbits Against Myocardial Infarction , 2001, Circulation.

[15]  P. Ping,et al.  PKCepsilon modulates NF-kappaB and AP-1 via mitogen-activated protein kinases in adult rabbit cardiomyocytes. , 2000, American journal of physiology. Heart and circulatory physiology.

[16]  P. Ping,et al.  The late phase of ischemic preconditioning is abrogated by targeted disruption of the inducible NO synthase gene. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[17]  R. Bolli,et al.  Demonstration of an early and a late phase of ischemic preconditioning in mice. , 1998, American journal of physiology. Heart and circulatory physiology.

[18]  R. Bolli,et al.  Time course of late preconditioning against myocardial stunning in conscious pigs. , 1996, Circulation research.

[19]  A. Cohen-Solal,et al.  [Ventricular "remodeling" after myocardial infarction]. , 1991, Archives des maladies du coeur et des vaisseaux.

[20]  M. Pfeffer,et al.  Ventricular Remodeling After Myocardial Infarction: Experimental Observations and Clinical Implications , 1990, Circulation.

[21]  R. Bolli,et al.  Activation of the complement system by recombinant tissue plasminogen activator. , 1987, Journal of the American College of Cardiology.